Time to next relapse as a primary endpoint in neuromyelitis optica clinical trials. by Kitley, J, Leite, M, Elsone, L, Jacob, A, Palace, J

Time to next relapse as a primary endpoint in neuromyelitis optica clinical trials by Kitley, J, Leite, M, Elsone, L, Jacob, A, Palace, J

RELAPSING AQP4 ANTIBODY NEGATIVE NMO WITH MOG ANTIBODIES by Elsone, L, Waters, P, Woodhall, M, Mutch, K, Jacob, A

METHOTREXATE MAY BE AN ALTERNATIVE TO AZATHIOPRINE IN NEUROMYELITIS OPTICA WITH AQUAPORIN-4 ANTIBODIES by Kitley, J, Elsone, L, George, J, Jacob, A, Leite, M, Palace, J

TREATMENT OF NEUROMYELITIS OPTICA WITH AZATHIOPRINE by Elsone, L, Leite, M, Brown, R, McNeillis, B, Palace, J, Boggild, Jacob, M

Methotrexate is an alternative to azathioprine in neuromyelitis optica spectrum disorders with aquaporin-4 antibodies by Kitley, J, Elsone, L, George, J, Waters, P, Woodhall, M, Vincent, A, Jacob, A, Leite, M, Palace, J

Methotrexate is an alternative to azathioprine in neuromyelitis optica spectrum disorders with aquaporin-4 antibodies. by Kitley, J, Elsone, L, George, J, Waters, P, Woodhall, M, Vincent, A, Jacob, A, Leite, M, Palace, J

Glycine receptor antibody — a marker for NMO/ NON-MS demyelination? by Hamid, S, Elsone, L, Waters, P, Woodhall, M, Mutch, K, Rafferty, C, Tang, L, Solomon, T, Vincent, A, Jacob, A

Alternative antigen targets in aquaporin-4 antibodynegative neuromyelitis optica spectrum disorders by Kitley, J, Kattenbelt, M, Waters, P, Woodhall, M, George, J, Elsone, L, Jacob, A, Leite, M, Palace, J, Vincent, A

Seasonal pattern of variation in neuromyelitis optica relapses by Elsone, L, Luppe, S, Kitley, J, Chater-Lea, P, Harding, K, Mutch, K, Leite, M, Palace, J, Robertson, N, Jacob, A

Seasonal distribution of attacks in aquaporin-4 antibody disease and myelin-oligodendrocyte antibody disease. by Dos Passos, GR, Elsone, L, Luppe, S, Kitley, J, Messina, S, Rodríguez Cruz, PM, Harding, K, Mutch, K, Leite, MI, Robertson, N, Jacob, A, Palace, J

Long term efficacy, adherence and reasons for discontinuation in 103 cases of neuromyelitis optica treated with azathioprine: a multicentre study from the United Kingdom by Elsone, L, Kitley, J, Luppe, S, Lythgoe, D, Brown, R, McNeillis, B, Goh, Y, Mutch, K, Jacob, S, Leite, M, Robertson, N, Palace, J, Jacob, A

Is azathioprine effective in highly-active neuromyelitis optica? A multicentre study from the United Kingdom by Elsone, L, Kitley, J, Luppe, S, Lythgoe, D, Brown, R, McNeillis, B, Goh, Y, Mutch, K, Jacob, S, Leite, M, Robertson, N, Palace, J, Jacob, A

Long-term efficacy, tolerability and retention rate of azathioprine in 103 aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder patients: a multicentre retrospectiv... by Elsone, L, Kitley, J, Luppe, S, Lythgoe, D, Mutch, K, Jacob, S, Brown, R, Moss, K, McNeillis, B, Goh, Y, Leite, M, Robertson, N, Palace, J, Jacob, A

Prognostic factors and disease course in aquaporin-4 antibody-positive patients with neuromyelitis optica spectrum disorder from the United Kingdom and Japan. by Kitley, J, Leite, M, Nakashima, I, Waters, P, McNeillis, B, Brown, R, Takai, Y, Takahashi, T, Misu, T, Elsone, L, Woodhall, M, George, J, Boggild, M, Vincent, A, Jacob, A, Fujihara, K, Palace, J

Prognostic factors and disease course in aquaporin-4 antibody-positive patients with neuromyelitis optica spectrum disorder from the United Kingdom and Japan by Kitley, J, Leite, M, Nakashima, I, Waters, P, McNeillis, B, Brown, R, Takai, Y, Takahashi, T, Misu, T, Elsone, L, Woodhall, M, George, J, Boggild, M, Vincent, A, Jacob, A, Fujihara, K, Palace, J

Area postrema syndrome: Frequency, criteria, and severity in AQP4-IgG–positive NMOSD by Shosha, E, Dubey, D, Palace, J, Nakashima, I, Jacob, A, Fujihara, K, Takahashi, T, Whittam, D, Leite, M, Misu, T, Yoshiki, T, Messina, S, Elsone, L, Majed, M, Flanagan, E, Gadoth, A, Huebert, C, Sagen, J, Greenberg, B, Levy, M, Banerjee, A, Weinshenker, B, Pittock, S

Characterization of neuromyelitis optica and neuromyelitis optica spectrum disorder patients with a late onset. by Collongues, N, Marignier, R, Jacob, A, Leite, M, Siva, A, Paul, F, Zephir, H, Akman-Demir, G, Elsone, L, Jarius, S, Papeix, C, Mutch, K, Saip, S, Wildemann, B, Kitley, J, Karabudak, R, Aktas, O, Kuscu, D, Altintas, A, Palace, J, Confavreux, C, De Seze, J

Characterization of NMO and NMOSD Patients with a Late Onset by Collongues, N, Marignier, R, Jacob, A, Siva, A, Paul, F, Zephir, H, Leite, M, Akman-Demir, G, Elsone, L, Jarius, S, Papeix, C, Mutch, K, Saip, S, Wildemann, B, Kitley, J, Karabudak, R, Aktas, O, Kuscu, D, Altintas, A, Palace, J, Confavreux, C, De Seze, J